T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Becton Dickinson
BDX
|
+$3.46B |
| 2 |
UnitedHealth
UNH
|
+$2.79B |
| 3 |
Salesforce
CRM
|
+$2.38B |
| 4 |
Sherwin-Williams
SHW
|
+$1.41B |
| 5 |
Philip Morris
PM
|
+$1.34B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$4.44B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$2.97B |
| 3 |
GE Aerospace
GE
|
+$2.3B |
| 4 |
HCA Healthcare
HCA
|
+$2.17B |
| 5 |
American International
AIG
|
+$1.68B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.68% |
| 2 | Healthcare | 19.49% |
| 3 | Consumer Discretionary | 13.07% |
| 4 | Financials | 11.18% |
| 5 | Communication Services | 8.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1626
Erie Indemnity
ERIE
$13.3B
| $1.9M | ﹤0.01% |
9,876
+848
| +9% | +$147K |
|
1627
iShares MSCI Saudi Arabia ETF
KSA
$625M
| $1.89M | ﹤0.01% |
45,700
+33,700
| +281% | +$1.57M |
|
1628
Old National Bancorp
ONB
$10.4B
| $1.89M | ﹤0.01% |
127,886
-10,862
| -8% | -$167K |
|
|
OLO
1629
DELISTED
Olo Inc
OLO
| $1.87M | ﹤0.01% |
189,901
+14,079
| +8% | +$153K |
|
1630
Rogers Corp
ROG
$2.52B
| $1.87M | ﹤0.01% |
7,141
+721
| +11% | +$192K |
|
|
LSXMK
1631
DELISTED
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
| $1.87M | ﹤0.01% |
67,029
+642
| +1% | +$20.2K |
|
|
TCDA
1632
DELISTED
Tricida, Inc. Common Stock
TCDA
| $1.86M | ﹤0.01% |
+192,353
| New | +$1.83M |
|
1633
PubMatic
PUBM
$792M
| $1.85M | ﹤0.01% |
116,644
+3,981
| +4% | +$85.3K |
|
1634
Independence Realty Trust
IRT
$4.02B
| $1.84M | ﹤0.01% |
88,681
+1,122
| +1% | +$27K |
|
|
VRNT
1635
DELISTED
Verint Systems
VRNT
| $1.82M | ﹤0.01% |
43,044
-4,010
| -9% | -$200K |
|
1636
WesBanco
WSBC
$4.12B
| $1.82M | ﹤0.01% |
57,446
-17,995
| -24% | -$592K |
|
1637
Sprout Social
SPT
$597M
| $1.82M | ﹤0.01% |
31,292
+3,151
| +11% | +$183K |
|
1638
Harley-Davidson
HOG
$2.89B
| $1.81M | ﹤0.01% |
57,221
-3,672
| -6% | -$131K |
|
1639
Natera
NTRA
$44.8B
| $1.81M | ﹤0.01% |
51,126
+9,045
| +21% | +$335K |
|
1640
LivaNova
LIVN
$4.46B
| $1.81M | ﹤0.01% |
28,970
+308
| +1% | +$21.8K |
|
1641
Oscar Health
OSCR
$9.98B
| $1.79M | ﹤0.01% |
422,332
+292,016
| +224% | +$1.86M |
|
1642
Terex
TEX
$7.75B
| $1.79M | ﹤0.01% |
65,513
-541,816
| -89% | -$18M |
|
1643
MDU Resources
MDU
$4.34B
| $1.79M | ﹤0.01% |
174,306
+5,052
| +3% | +$51.4K |
|
1644
Acuity Brands
AYI
$10.7B
| $1.79M | ﹤0.01% |
11,602
+261
| +2% | +$44.3K |
|
1645
CNO Financial Group
CNO
$5.1B
| $1.78M | ﹤0.01% |
98,289
-4,095
| -4% | -$87.6K |
|
1646
Park National Corp
PRK
$3.78B
| $1.77M | ﹤0.01% |
14,617
+98
| +0.7% | +$11.8K |
|
1647
Patterson-UTI
PTEN
$4.32B
| $1.77M | ﹤0.01% |
112,186
-3,484
| -3% | -$58.5K |
|
|
HTLF
1648
DELISTED
Heartland Financial USA, Inc.
HTLF
| $1.76M | ﹤0.01% |
42,486
+2,680
| +7% | +$118K |
|
1649
Yeti Holdings
YETI
$3.43B
| $1.76M | ﹤0.01% |
40,765
+1,462
| +4% | +$71K |
|
1650
Kontoor Brands
KTB
$4.67B
| $1.76M | ﹤0.01% |
52,724
+730
| +1% | +$28.4K |
|
Similar funds
T. Rowe Price Associates's Q2 2022 Portfolio in Review
As of Q2 2022, T. Rowe Price Associates held 3,063 positions worth $791B, down 20% from $992B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
T. Rowe Price Associates's Q2 2022 filing shows 88 new, 1,490 increased, 1,207 reduced and 101 closed positions. Its largest new stake was ESAB: 6,073,363 shares worth $266M. The largest sale was Meta Platforms (Facebook), an estimated $4.44B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2022 buy was ESAB: 6,073,363 shares worth $266M.
- T. Rowe Price Associates added most to Becton Dickinson in Q2 2022, an estimated $3.46B increase.
- T. Rowe Price Associates's biggest Q2 2022 reduction was Meta Platforms (Facebook), cutting an estimated $4.44B.
- T. Rowe Price Associates fully exited Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q2 2022, selling an estimated $364M.
- T. Rowe Price Associates's ten largest holdings make up 26% of its $791B portfolio in Q2 2022.
- T. Rowe Price Associates opened 88 new positions and closed 101 in Q2 2022.
- T. Rowe Price Associates's portfolio value fell 20% quarter-over-quarter to $791B.
Based on T. Rowe Price Associates's 13F filing for Q2 2022, filed 15 Aug 2022.